person · Reporting owner

Sankaran Sid

Disclosed activity across 3 companies

Tapewire entity: 30763
SEC CIK: 0001509066

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083	Executive VP & CFO	September 28, 2018	October 01, 2018
Oscar Health, Inc.OSCR · Entity 3582	Director	October 08, 2026	October 13, 2026
SiriusPoint LtdSPNT · Entity 554	Director · President and CEO	April 14, 2022	April 18, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMERICAN INTERNATIONAL GROUP, INC.

Report date September 28, 2018 · Filed October 01, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
2015 Performance Share UnitsSEC Table II · derivative / convertible security	Direct	6,035	Reported balance After 2018-09-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-09-28 · Grant · Acquired 36 · Balance 6,035 F1: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis.
2017 Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	15,936	Reported balance After 2018-09-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-09-28 · Grant · Acquired 95 · Balance 15,936 F2: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.
2018 Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	17,508	Reported balance After 2018-09-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-09-28 · Grant · Acquired 105 · Balance 17,508 F3: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	96,579	Reported balance After 2018-09-28 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-09-28 · Grant · Acquired 576 · Balance 96,579 F4: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.

Filing footnotes · ownership attribution and instrument terms

F1: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis.

F2: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.

F3: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.

F4: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis.

Oscar Health, Inc.

Report date October 08, 2026 · Filed October 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Stock UnitSEC Table II · derivative / convertible security	Direct	3,533	Reported balance After 2026-10-08 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-10-08 · Grant · Acquired 1,472 · Balance 3,533 F1: Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. F3: The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on October 8, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F2: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

Filing footnotes · ownership attribution and instrument terms

F1: Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

F2: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

F3: The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on October 8, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

SiriusPoint Ltd

Report date April 14, 2022 · Filed April 18, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common SharesSEC Table I · non-derivative	Direct	1,508,116	Reported balance After 2022-04-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2022-04-14 · Tax withholding · Disposed 21,130 · Balance 1,508,116 F1: Shares withheld to cover current tax liabilities in connection with the vesting of restricted share units. F2: On April 13, 2022, the last preceding business day prior to the transaction, the closing price of the Company's common shares on the New York Stock Exchange was $6.54. F3: Includes restricted shares.

Filing footnotes · ownership attribution and instrument terms

F1: Shares withheld to cover current tax liabilities in connection with the vesting of restricted share units.

F2: On April 13, 2022, the last preceding business day prior to the transaction, the closing price of the Company's common shares on the New York Stock Exchange was $6.54.

F3: Includes restricted shares.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 08, 2026 Filed Oct 13, 2026 20:16 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantDeferred Stock Unit · Derivative	1,472	$33.10	$48,723.20	Disclosure SEC source: 0001509066-26-000008 · wk-form4_1791922609.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,533 Underlying: Class A Common Stock · 1,472 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. F3 · price: The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on October 8, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F2 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. F2 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. Read SEC document
July 09, 2026 Filed Jul 13, 2026 20:16 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantDeferred Stock Unit · Derivative	858	$31.20	$26,769.60	Disclosure SEC source: 0001509066-26-000006 · wk-form4_1783973764.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,061 Underlying: Class A Common Stock · 858 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. F3 · price: The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on July 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F2 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. F2 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. Read SEC document
June 04, 2026 Filed Jun 8, 2026 20:18 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantClass A Common Stock	8,475	$0.00	$0.00	Disclosure SEC source: 0001509066-26-000004 · wk-form4_1780949894.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,609 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer. Read SEC document
April 09, 2026 Filed Apr 13, 2026 20:16 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantDeferred Stock Unit · Derivative	1,203	$14.54	$17,491.62	Disclosure SEC source: 0001509066-26-000002 · wk-form4_1776111398.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,203 Underlying: Class A Common Stock · 1,203 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. F3 · price: The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on April 9, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person. F2 · derivative.exercise_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. F2 · derivative.expiration_date: The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date. Read SEC document
June 04, 2025 Filed Jun 6, 2025 20:23 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantClass A Common Stock	14,134	$0.00	$0.00	Disclosure SEC source: 0001562180-25-004564 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,134 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer. Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:51 UTC	Oscar Health, Inc. OSCR · Entity 3582	GiftClass A Common Stock	295,687	$0.00	$0.00	Disclosure SEC source: 0001562180-25-001141 · primarydocument.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Victoria Family LLC Disclosed balance after: 795,686 F1 · ownership.nature: Victoria Family LLC is wholly owned by the fiduciaries of The Victoria 2020 Trust. Mr. Sankaran is the Investment Adviser to The Victoria 2020 Trust. Mr. Sankaran disclaims beneficial ownership of the shares held of record by Victoria Family LLC except to the extent of his pecuniary interest therein. Read SEC document
February 07, 2025 Filed Feb 11, 2025 23:51 UTC	Oscar Health, Inc. OSCR · Entity 3582	GiftClass A Common Stock	295,687	$0.00	$0.00	Disclosure SEC source: 0001562180-25-001141 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document
September 05, 2023 Filed Sep 6, 2023 23:07 UTC	Oscar Health, Inc. OSCR · Entity 3582	SaleClass A Common Stock	139,635	$6.25	$872,718.75	Disclosure SEC source: 0001562180-23-006756 · primarydocument.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,687 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. Read SEC document
September 01, 2023 Filed Sep 6, 2023 23:07 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionRestricted Stock Units · Derivative	227,848	$0.00	$0.00	Disclosure SEC source: 0001562180-23-006756 · primarydocument.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,848 Underlying: Class A Common Stock · 227,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in four equal quarterly installments over the one-year period beginning December 1, 2022. F4 · derivative.expiration_date: The restricted stock units vest in four equal quarterly installments over the one-year period beginning December 1, 2022. Read SEC document
September 01, 2023 Filed Sep 6, 2023 23:07 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionClass A Common Stock	227,848	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-23-006756 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 435,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document
June 02, 2023 Filed Jun 5, 2023 21:32 UTC	Oscar Health, Inc. OSCR · Entity 3582	SaleClass A Common Stock	137,826	$7.15	$985,455.90	Disclosure SEC source: 0001562180-23-004834 · primarydocument.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,474 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. Read SEC document
June 01, 2023 Filed Jun 5, 2023 21:32 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionRestricted Stock Units · Derivative	227,848	$0.00	$0.00	Disclosure SEC source: 0001562180-23-004834 · primarydocument.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 455,696 Underlying: Class A Common Stock · 227,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in four equal quarterly installments over the one-year period beginning December 1, 2022. F4 · derivative.expiration_date: The restricted stock units vest in four equal quarterly installments over the one-year period beginning December 1, 2022. Read SEC document
June 01, 2023 Filed Jun 5, 2023 21:32 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionClass A Common Stock	227,848	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-23-004834 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document
March 02, 2023 Filed Mar 3, 2023 21:12 UTC	Oscar Health, Inc. OSCR · Entity 3582	SaleClass A Common Stock	110,396	$4.75	$524,436.20	Disclosure SEC source: 0001562180-23-002358 · primarydocument.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,452 F2 · shares: The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:12 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionRestricted Stock Units · Derivative	227,848	$0.00	$0.00	Disclosure SEC source: 0001562180-23-002358 · primarydocument.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,544 Underlying: Class A Common Stock · 227,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units will vest in four equal quarterly installments over the one-year period beginning December 1, 2022. F4 · derivative.expiration_date: The restricted stock units will vest in four equal quarterly installments over the one-year period beginning December 1, 2022. Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:12 UTC	Oscar Health, Inc. OSCR · Entity 3582	Exercise / conversionClass A Common Stock	227,848	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-23-002358 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · Interim CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document
November 09, 2022 Filed Nov 14, 2022 21:13 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantRestricted Stock Units · Derivative	911,392	$0.00	$0.00	Disclosure SEC source: 0001562180-22-007623 · primarydocument.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · Senior Advisor 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911,392 Underlying: Class A Common Stock · 911,392 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest in four equal quarterly installments over the one-year period beginning December 1, 2022. F2 · derivative.expiration_date: The restricted stock units will vest in four equal quarterly installments over the one-year period beginning December 1, 2022. Read SEC document
April 14, 2022 Filed Apr 18, 2022 20:05 UTC	SiriusPoint Ltd SPNT · Entity 554	Tax withholdingCommon Shares	21,130	$6.54	$138,190.20	Disclosure SEC source: 0001576018-22-000068 · wf-form4_165031233689940.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,508,116 F1 · shares: Shares withheld to cover current tax liabilities in connection with the vesting of restricted share units. F2 · price: On April 13, 2022, the last preceding business day prior to the transaction, the closing price of the Company's common shares on the New York Stock Exchange was $6.54. F3 · balance_after: Includes restricted shares. Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:56 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantOptions (Right to Buy) · Derivative	409,483	$0.00 Strike: $6.76	$0.00	Disclosure SEC source: 0001576018-22-000057 · wf-form4_164945134696560.xml · derivative · entry 3 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,483 Underlying: Common Shares · 409,483 shares Expires 2032-04-06 F4 · shares: The option becomes fully exercisable on the third anniversary of the date of grant. Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:56 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantCommon Shares	37,826	$0.00	$0.00	Disclosure SEC source: 0001576018-22-000057 · wf-form4_164945134696560.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,529,246 F3 · shares: Represents 37,826 performance based restricted share units achieved following the achievement of 66% of target, such restricted share units shall vest on April 14, 2024. Read SEC document
April 06, 2022 Filed Apr 8, 2022 20:56 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantCommon Shares	509,657	$0.00	$0.00	Disclosure SEC source: 0001576018-22-000057 · wf-form4_164945134696560.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,491,420 F1 · shares: Includes 509,657 restricted share units granted under the SiriusPoint Ltd. 2013 Omnibus Incentive Plan that vest in equal installments over three years based on continued employment. F2 · balance_after: Includes restricted shares. Read SEC document
February 26, 2022 Filed Mar 1, 2022 21:24 UTC	SiriusPoint Ltd SPNT · Entity 554	Tax withholdingCommon Shares	70,512	$7.45	$525,314.40	Disclosure SEC source: 0001576018-22-000030 · wf-form4_164616987204962.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981,763 F1 · shares: Shares withheld to cover current tax liabilities in connection with the vesting of restricted shares. F2 · price: On February 25, 2022, the last preceding business day prior to the transaction, the closing price of the Company's common shares on the New York Stock Exchange was $7.45. F3 · balance_after: Includes restricted shares. Read SEC document
August 03, 2021 Filed Feb 9, 2022 01:51 UTC	Oscar Health, Inc. OSCR · Entity 3582	GiftCommon Stock	166,666	$0.00	$0.00	Disclosure SEC source: 0001562180-22-001250 · primarydocument.xml · nonDerivative · entry 2 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Victoria Family LLC Disclosed balance after: 499,999 F1 · shares: On August 3, 2021, the reporting person transferred 166,666 shares of common stock to the Victoria Family LLC, of which the reporting person is Investment Adviser. F2 · ownership.nature: Victoria Family LLC is wholly owned by the fiduciaries of The Victoria 2020 Trust. Mr. Sankaran is the Investment Adviser to The Victoria 2020 Trust. Mr. Sankaran disclaims beneficial ownership of the shares held of record by Victoria Family LLC except to the extent of his pecuniary interests therein. Read SEC document
August 03, 2021 Filed Feb 9, 2022 01:51 UTC	Oscar Health, Inc. OSCR · Entity 3582	GiftCommon Stock	166,666	$0.00	$0.00	Disclosure SEC source: 0001562180-22-001250 · primarydocument.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: On August 3, 2021, the reporting person transferred 166,666 shares of common stock to the Victoria Family LLC, of which the reporting person is Investment Adviser. Read SEC document
April 30, 2021 Filed May 4, 2021 20:23 UTC	SiriusPoint Ltd SPNT · Entity 554	Tax withholdingCommon Shares	1,853	$10.60	$19,641.80	Disclosure SEC source: 0001576018-21-000097 · wf-form4_162015976166259.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052,275 F1 · shares: Shares withheld to cover current tax liabilities in connection with the vesting of restricted shares. F2 · balance_after: Includes restricted shares. Read SEC document
April 14, 2021 Filed Apr 16, 2021 20:53 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantOptions (Right to Buy) · Derivative	235,615	$0.00 Strike: $10.36	$0.00	Disclosure SEC source: 0001576018-21-000091 · wf-form4_161860634701649.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,615 Underlying: Common Shares · 235,615 shares Expires 2031-04-14 F3 · derivative.exercise_date: The options shall vest and become exercisable on the third anniversary of the grant date, subject to continued employment through each such vesting date. The options expire on the tenth anniversary of the grant date. F4 · derivative.underlying_shares: Grant of options to purchase Common Shares under the Plan, exempt under Rule 16b-3. Read SEC document
April 14, 2021 Filed Apr 16, 2021 20:53 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantCommon Shares	114,623	$0.00	$0.00	Disclosure SEC source: 0001576018-21-000091 · wf-form4_161860634701649.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054,128 F1 · shares: Includes 114,623 restricted share units granted under the SiriusPoint Ltd. 2013 Omnibus Incentive Plan (the "Plan") that vest in equal annual installments over three years based on continued employment. F2 · balance_after: Includes restricted shares. Read SEC document
March 05, 2021 Filed Mar 5, 2021 23:14 UTC	Oscar Health, Inc. OSCR · Entity 3582	GrantRestricted Stock Units · Derivative	17	$0.00	$0.00	Disclosure SEC source: 0000899243-21-010182 · doc4.xml · derivative · entry 3 Sankaran Sid · CIK 0001509066 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Class A Common Stock · 17 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. F3 · derivative.expiration_date: The restricted stock units vest upon the earlier of (i) 180 days after the IPO date, or (ii) the second day following the expiration of the underwriter-mandated lock-up period associated with the Issuer's initial public offering. Read SEC document
March 05, 2021 Filed Mar 5, 2021 23:14 UTC	Oscar Health, Inc. OSCR · Entity 3582	SaleClass A Common Stock	71,666	$39.00	$2,794,974.00	Disclosure SEC source: 0000899243-21-010182 · doc4.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,666 Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantOptions (Right to Buy) · Derivative	400,000	$0.00 Strike: $15.00	$0.00	Disclosure SEC source: 0001209191-21-016300 · doc4.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Shares · 400,000 shares Expires 2031-02-26 F2 · shares: Grant of options to purchase Common Shares under the SiriusPoint Ltd. 2013 Omnibus Incentive Plan, as amended, exempt under Rule 16b-3. F3 · derivative.exercise_date: The options shall vest and become exercisable in equal installments on each of the first five anniversaries of the grant date, as follows: 80,000 options on February 26, 2022; 80,000 options on February 26, 2023; 80,000 options on February 26, 2024; 80,000 options on February 26, 2025 and 80,000 options on February 26, 2026, subject to continued employment through each such vesting date. The options expire on the tenth anniversary of the grant date. F3 · derivative.expiration_date: The options shall vest and become exercisable in equal installments on each of the first five anniversaries of the grant date, as follows: 80,000 options on February 26, 2022; 80,000 options on February 26, 2023; 80,000 options on February 26, 2024; 80,000 options on February 26, 2025 and 80,000 options on February 26, 2026, subject to continued employment through each such vesting date. The options expire on the tenth anniversary of the grant date. Read SEC document
February 26, 2021 Filed Mar 2, 2021 22:29 UTC	SiriusPoint Ltd SPNT · Entity 554	GrantCommon Shares	523,809	$0.00	$0.00	Disclosure SEC source: 0001209191-21-016300 · doc4.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 939,505 F1 · balance_after: Includes restricted shares. Read SEC document
August 06, 2020 Filed Aug 7, 2020 23:11 UTC	SiriusPoint Ltd TPRE · Entity 554	GrantCommon Shares	1,534	$0.00	$0.00	Disclosure SEC source: 0001576018-20-000106 · wf-form4_159684120734400.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,176 F1 · balance_after: Includes restricted shares. Read SEC document
August 06, 2020 Filed Aug 10, 2020 21:29 UTC	SiriusPoint Ltd TPRE · Entity 554	GrantCommon Shares	364,520	$0.00	$0.00	Disclosure SEC source: 0001576018-20-000116 · wf-form4_159709492372383.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,696 F1 · balance_after: Includes restricted shares. Read SEC document
May 05, 2020 Filed May 6, 2020 20:33 UTC	SiriusPoint Ltd TPRE · Entity 554	GrantCommon Shares	17,434	$0.00	$0.00	Disclosure SEC source: 0001576018-20-000065 · wf-form4_158879719831579.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,642 F1 · balance_after: Includes restricted shares. Read SEC document
March 03, 2020 Filed Mar 4, 2020 22:00 UTC	SiriusPoint Ltd TPRE · Entity 554	PurchaseCommon Shares	25,000	$9.37	$234,197.50	Disclosure SEC source: 0001576018-20-000038 · wf-form4_158335922124393.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,208 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.159 to $9.59 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document
August 08, 2019 Filed Aug 12, 2019 20:10 UTC	SiriusPoint Ltd TPRE · Entity 554	GrantCommon Shares	7,208	$0.00	$0.00	Disclosure SEC source: 0001576018-19-000079 · wf-form4_156564062361855.xml · nonDerivative · entry 1 Sankaran Sid · CIK 0001509066 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,208 F1 · balance_after: Includes restricted shares Read SEC document
September 28, 2018 Filed Oct 1, 2018 20:32 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	GrantRestricted Stock Units · Derivative	576	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-013916 · doc4.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,579 Underlying: Common Stock · 576 shares Expires not disclosed F4 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
September 28, 2018 Filed Oct 1, 2018 20:32 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2018 Restricted Stock Units · Derivative	105	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-013916 · doc4.xml · derivative · entry 3 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,508 Underlying: Common Stock · 105 shares Expires not disclosed F3 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · shares: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
September 28, 2018 Filed Oct 1, 2018 20:32 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2017 Restricted Stock Units · Derivative	95	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-013916 · doc4.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,936 Underlying: Common Stock · 95 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · shares: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
September 28, 2018 Filed Oct 1, 2018 20:32 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2015 Performance Share Units · Derivative	36	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-013916 · doc4.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,035 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
June 28, 2018 Filed Jul 2, 2018 20:49 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	GrantRestricted Stock Units · Derivative	557	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-011060 · doc4.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,003 Underlying: Common Stock · 557 shares Expires not disclosed F4 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
June 28, 2018 Filed Jul 2, 2018 20:49 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2018 Restricted Stock Units · Derivative	101	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-011060 · doc4.xml · derivative · entry 3 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,403 Underlying: Common Stock · 101 shares Expires not disclosed F3 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · shares: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
June 28, 2018 Filed Jul 2, 2018 20:49 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2017 Restricted Stock Units · Derivative	92	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-011060 · doc4.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,841 Underlying: Common Stock · 92 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · shares: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
June 28, 2018 Filed Jul 2, 2018 20:49 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2015 Performance Share Units · Derivative	34	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-011060 · doc4.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,999 Underlying: Common Stock · 34 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:33 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	GrantRestricted Stock Units · Derivative	556	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-006907 · doc4.xml · derivative · entry 4 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,446 Underlying: Common Stock · 556 shares Expires not disclosed F4 · derivative.exercise_price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · shares: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · price: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.exercise_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F4 · derivative.expiration_date: These securities are dividend equivalent rights in the form of Restricted Stock Units with respect to Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The Restricted Stock Units vest in March 2019, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:33 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2018 Restricted Stock Units · Derivative	100	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-006907 · doc4.xml · derivative · entry 3 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,302 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · shares: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · price: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F3 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2018 Restricted Stock Units with respect to 2018 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:33 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2017 Restricted Stock Units · Derivative	92	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-006907 · doc4.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,749 Underlying: Common Stock · 92 shares Expires not disclosed F2 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · shares: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · price: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. F2 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2017 Restricted Stock Units with respect to 2017 Restricted Stock Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan. The 2017 Restricted Stock Units vest in January 2020, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
March 29, 2018 Filed Apr 2, 2018 20:33 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2015 Performance Share Units · Derivative	35	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-18-006907 · doc4.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,965 Underlying: Common Stock · 35 shares Expires not disclosed F1 · derivative.exercise_price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · shares: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · price: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.exercise_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. F1 · derivative.expiration_date: These securities are dividend equivalent rights in the form of 2015 Performance Share Units with respect to 2015 Performance Share Units previously awarded under the American International Group, Inc. 2013 Omnibus Incentive Plan and earned as determined by AIG's Compensation and Management Resources Committee in January 2018 based on pre-established performance goals for the three-year performance period ended December 31, 2017. The earned 2015 Performance Share Units vest one-third in January of each of 2018, 2019 and 2020 and are settled in shares of AIG Common Stock on a 1 to 1 basis. Read SEC document
March 13, 2018 Filed Mar 15, 2018 20:34 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2018 Stock Option (Right to Buy) · Derivative	86,224	$0.00 Strike: $55.94	$0.00	Disclosure SEC source: 0001225208-18-006222 · doc4.xml · derivative · entry 2 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,224 Underlying: Common Stock · 86,224 shares Expires 2028-03-13 Read SEC document
March 13, 2018 Filed Mar 15, 2018 20:34 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	Grant2018 Restricted Stock Units · Derivative	17,202	$0.00	$0.00	Disclosure SEC source: 0001225208-18-006222 · doc4.xml · derivative · entry 1 Sankaran Sid · CIK 0001509066 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,202 Underlying: Common Stock · 17,202 shares Expires not disclosed F1 · derivative.exercise_price: The 2018 Restricted Stock Units convert to AIG Common Stock on a 1 to 1 basis. F2 · shares: Represents the grant of 2018 Restricted Stock Units. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2018 Restricted Stock Units. F2 · derivative.exercise_date: Represents the grant of 2018 Restricted Stock Units. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2018 Restricted Stock Units. F2 · derivative.expiration_date: Represents the grant of 2018 Restricted Stock Units. The 2018 Restricted Stock Units vest in January 2021, subject to the reporting person's continued employment through the vesting date, and are settled in shares of AIG Common Stock. The award includes dividend equivalent rights payable in the form of additional 2018 Restricted Stock Units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.